scholarly journals Does low molecular weight heparin really protect against prosthetic valve thrombosis during pregnancy with strict anti-Xa monitoring?

2021 ◽  
Vol 60 (5) ◽  
pp. 959-960
Author(s):  
Macit Kalçık ◽  
Ahmet Güner ◽  
Semih Kalkan ◽  
Mehmet Özkan
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Prosthetic Valve ◽  
Low Molecular Weight ◽  
Prosthetic Valve Thrombosis ◽  
Valve Thrombosis

MECHANICAL HEART VALVES AND PREGNANCY

2007 ◽  
Vol 18 (4) ◽  
pp. 311-331 ◽  
Author(s):  
CYNTHIA MAXWELL ◽  
MATHEW SERMER
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Heart Valves ◽  
First Trimester ◽  
Mechanical Heart Valves ◽  
Low Molecular Weight ◽  
Valve Thrombosis ◽  
First Trimester Of Pregnancy ◽  
Primary Agent ◽  
In Pregnancy

Mechanical heart valves pose a particular challenge in pregnancy, as the primary agent used to prevent valve thrombosis, coumadin (warfarin), is a known teratogen. Alternatives to coumadin, such as unfractionated heparin (UFH) and low-molecular weight heparin (LMWH) are safer for the fetus, particularly during the first trimester of pregnancy, but expose the mother to potential valve failure. This review will examine these controversies and the complex literature regarding management in pregnancy.

Low-molecular-weight heparin in the prevention and treatment of thromboembolic disorders

1998 ◽  
Vol 1 (5) ◽  
pp. 166-174 ◽  
Author(s):  
Evelyn R Hermes De Santis ◽  
Betsy S Laumeister ◽  
Vidhu Bansal ◽  
Vandana Kataria ◽  
Preeti Loomba ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
Prevention And Treatment
Sign in / Sign up

Export Citation Format

Share Document